Navigation Links
Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference
Date:5/9/2013

SAN DIEGO, May 9, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman , President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas.  

The live presentation takes place on Thursday, May 16 at 11:20 a.m. Pacific Time / 2:20 p.m. Eastern Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for one month.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

 


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results
2. Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
3. Neurocrine Biosciences Reports Third Quarter 2012 Results
4. Neurocrine Biosciences Reports Second Quarter 2012 Results
5. Neurocrine Biosciences to Present at The 24th Annual Roth Conference
6. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
7. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
8. Provitro Biosciences Awarded First-Ever U.S. Patent For Large-Scale Production Of Bamboo Plants
9. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
10. Quanta BioSciences qRT-PCR technology recommended in newly published CDC protocol for detection of H7N9 Avian Influenza
11. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  Synthetic Biologics, ... anti-infective biologic and drug candidates targeting specific pathogens ... positive results from its final preclinical toxicology study ... (FDA) guidance, this bridging study was required to ... designed to prevent the devastating effects of ...
(Date:9/2/2014)... The inventors of tinAway, a novel treatment ... seeking support for development costs through a crowdfunding campaign. ... ), was launched on September 1, 2014. , tinAway ... is based on ten years of neuroscience research. ... software engineers, Dr. Ian Dixon and Mr. Tony Burgess, ...
(Date:8/31/2014)... September 01, 2014 Available spectra ... needs for research and cultivation of a wide ... Valoya’s proprietary LEDs with proven patented and pending ... uncompromised light uniformity in critical applications in contrast ... LEDs. , “Our customers have a large variety ...
(Date:8/29/2014)... circuits are based on electrons, but one of the ... circuits, i.e. circuits based on light (photons) instead of ... create a stream of single photons and control their ... of attempts to achieve this control, but now scientists ... a steady stream of photons emitted one at a ...
Breaking Biology Technology:Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 2Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 4Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 5tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 2tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 3tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 4tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 5Breakthrough in light sources for new quantum technology 2
... George Bush today spoke of energy during a visit ... resources, his remarks were directed toward new methods of ... oil. , ,In an address before employees at Johnson ... a new fuel cell for hybrid automobiles, he touted ...
... 65, is retiring as president and CEO of the company at ... company said on Tuesday. , ,Barr's replacement is already on hand: ... operations, has been named chief operating officer and will step up ... with the company for two decades and was involved in the ...
... all the news from DEMO '06 (if you haven't, check out ... 2006 in the "Watch Demo Videos" window and choose a company). ... inquiring minds that want to know what wasn't at DEMO. The ... look at hundreds of products and companies and bring only the ...
Cached Biology Technology:Bush praises Johnson Controls battery tech in Milwaukee visit 2Why companies don't get invited to the DEMO conference 2Why companies don't get invited to the DEMO conference 3
(Date:9/2/2014)... suburb , Observations and mapping by seismologists at ... days after the August 24 earthquake in northern California ... much damage in the region, according to a post ... Geophysical Union. , From this week,s ... Our Curiosity , Selecting where the next Mars ...
(Date:9/2/2014)... In an article in the September issue of ... Gulf of Mexico microbial communities in the aftermath ... revealing population-level responses of hydrocarbon-degrading microbes to the ... unique opportunity to study the responses of indigenous ... Surveys of genetic identifiers within cells known as ...
(Date:9/2/2014)... published paper provides a history of scientific research ... wildlife in these systems, and sets an agenda ... , The paper, "Mountain gloom and mountain glory ... change in mountain regions," appears online in the ... Charles C. Chester of Tufts University, Jodi A. ...
Breaking Biology News(10 mins):This week From AGU: California earthquake, future Mars rovers, models underestimate ozone 2Changing microbial dynamics in the wake of the Macondo blowout 2An uphill climb for mountain species? 2An uphill climb for mountain species? 3
... acknowledge the need to obtain their energy supply from ... how his team have developed a new anaerobic digestion ... wind turbines. These reactors use a consortium of methanogenic ... produce biogas (a mixture of methane and carbon) which ...
... Much as an anthropologist can study populations of people ... social structures, some marine microbiologists read the genome of ... environments and lifestyles. Using a relatively new ... entire genomes of different populations of the same microbe ...
... to intestinal cancer in mice More than 50% ... cytomegalovirus (HCMV) infection. For most people, infection produces no symptoms ... a long time. HCMV infects many cell types in the ... research, led by Sergio Lira, at Mount Sinai School of ...
Cached Biology News:Microscopic solutions to world's biggest problems 2Genomic comparison of ocean microbes reveals East-West divide in populations 2Genomic comparison of ocean microbes reveals East-West divide in populations 3JCI online early table of contents: Oct. 11, 2010 2JCI online early table of contents: Oct. 11, 2010 3JCI online early table of contents: Oct. 11, 2010 4JCI online early table of contents: Oct. 11, 2010 5JCI online early table of contents: Oct. 11, 2010 6JCI online early table of contents: Oct. 11, 2010 7
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Transcription factor Sp2. [Source:Uniprot/SWISSPROT;Acc:Q02086] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Proline-serine-threonine phosphatase-interacting protein 2...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Biology Products: